CRIXIVAN - 0006-0573-62 - (indinavir sulfate)

Alphabetical Index


Drug Information of CRIXIVAN

Product NDC: 0006-0573
Proprietary Name: CRIXIVAN
Non Proprietary Name: indinavir sulfate
Active Ingredient(s): 400    mg/1 & nbsp;   indinavir sulfate
Administration Route(s): ORAL
Dosage Form(s): CAPSULE
Coding System: National Drug Codes(NDC)

Labeler Information of CRIXIVAN

Product NDC: 0006-0573
Labeler Name: Merck Sharp & Dohme Corp.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020685
Marketing Category: NDA
Start Marketing Date: 19960313

Package Information of CRIXIVAN

Package NDC: 0006-0573-62
Package Description: 180 CAPSULE in 1 BOTTLE (0006-0573-62)

NDC Information of CRIXIVAN

NDC Code 0006-0573-62
Proprietary Name CRIXIVAN
Package Description 180 CAPSULE in 1 BOTTLE (0006-0573-62)
Product NDC 0006-0573
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name indinavir sulfate
Dosage Form Name CAPSULE
Route Name ORAL
Start Marketing Date 19960313
Marketing Category Name NDA
Labeler Name Merck Sharp & Dohme Corp.
Substance Name INDINAVIR SULFATE
Strength Number 400
Strength Unit mg/1
Pharmaceutical Classes HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC]

Complete Information of CRIXIVAN


General Information